These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25973024)

  • 1. Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target.
    Liu G; Song Y; Cui L; Wen Z; Lu X
    Int J Clin Exp Pathol; 2015; 8(2):1402-10. PubMed ID: 25973024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol hexaphosphate suppresses colorectal cancer cell proliferation via the Akt/GSK-3β/β-catenin signaling cascade in a 1,2-dimethylhydrazine-induced rat model.
    Yu W; Liu C; Li X; Yang F; Cheng L; Liu C; Song Y
    Eur J Pharmacol; 2017 Jun; 805():67-74. PubMed ID: 28315345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
    Gu M; Roy S; Raina K; Agarwal C; Agarwal R
    Cancer Res; 2009 Dec; 69(24):9465-72. PubMed ID: 19920184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.
    Schröterová L; Hasková P; Rudolf E; Cervinka M
    Oncol Rep; 2010 Mar; 23(3):787-93. PubMed ID: 20127021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein induces activation of the mitochondrial apoptosis pathway by inhibiting phosphorylation of Akt in colorectal cancer cells.
    Qin J; Teng J; Zhu Z; Chen J; Huang WJ
    Pharm Biol; 2016; 54(1):74-9. PubMed ID: 25880142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway.
    Li N; Bu X; Tian X; Wu P; Yang L; Huang P
    Nutr Cancer; 2012 Aug; 64(6):864-70. PubMed ID: 22860766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.
    Kapral M; Wawszczyk J; Jesse K; Paul-Samojedny M; Kuśmierz D; Węglarz L
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28972559
    [No Abstract]   [Full Text] [Related]  

  • 8. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 9. Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation.
    Vucenik I; Ramakrishna G; Tantivejkul K; Anderson LM; Ramljak D
    Breast Cancer Res Treat; 2005 May; 91(1):35-45. PubMed ID: 15868430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
    Gu M; Raina K; Agarwal C; Agarwal R
    Mol Carcinog; 2010 Jan; 49(1):1-12. PubMed ID: 19544333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCalpha.
    Jagadeesh S; Banerjee PP
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1361-7. PubMed ID: 16979586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol hexaphosphate hydrolysate competitively binds to AKT to inhibit the proliferation of colon carcinoma.
    Chen C; Yang F; Liu C; Cui L; Fu M; Song Y
    Oncol Rep; 2017 Nov; 38(5):2901-2910. PubMed ID: 28901472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells.
    Shen P; Wang HG; Li MM; Ma QY; Zhou CW; Pan F; Xie R
    Biomed Pharmacother; 2017 Aug; 92():78-85. PubMed ID: 28531803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
    Hu F; He Z; Sun C; Rong D
    Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
    Zhao X; Li X; Ren Q; Tian J; Chen J
    Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells.
    Yu Y; Yu X; Ma J; Tong Y; Yao J
    Int J Oncol; 2016 Jul; 49(1):285-93. PubMed ID: 27176231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
    Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
    Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.
    Huang GM; Sun Y; Ge X; Wan X; Li CB
    World J Gastroenterol; 2015 May; 21(20):6194-205. PubMed ID: 26034354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of gambogenic acid-induced apoptosis of melanoma B16 cells through PI3K/Akt/mTOR signaling pathways].
    Cheng H; Zhang X; Su JJ; Li QL
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1666-9. PubMed ID: 25095381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer.
    Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M
    Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.